Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)
1 other identifier
observational
112
1 country
1
Brief Summary
Investigating the diagnostic accuracy of online Ultrasonic Flow Ratio (UFR) assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived fractional flow reserve (FFR) as a reference standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedStudy Start
First participant enrolled
February 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2024
CompletedResults Posted
Study results publicly available
November 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedNovember 24, 2025
August 1, 2025
1.8 years
January 12, 2023
August 7, 2025
November 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic Accuracy of Onsite UFR
UFR was computed as the pressure ratio across a coronary stenosis, using FFR ≤0.80 as the reference standard for hemodynamically significant stenosis. The diagnostic performance of onsite UFR was assessed by the area under the receiver operating characteristic (ROC) curve analysis, with diagnostic accuracy defined as the percentage of all correctly classified cases (true positives and true negatives) in the total population.
baseline
Secondary Outcomes (4)
Sensitivity of Onsite UFR
baseline
Specificity of Onsite UFR
baseline
Sensitivity of Minimal Lumen Area (MLA)
baseline
Specificity of MLA
baseline
Eligibility Criteria
Patients with suspected ischemic heart disease who undergo coronary angiography.
You may qualify if:
- Subject must be ≥ 18 years
- Patients suspected with ischemic heart disease
- ≥ 1 diseased vessel with angiographic percent diameter stenosis between 40% and 80% in a vessel ≥ 2.5mm by visual estimation
- Target vessels are limited to major epicardial coronary arteries (left anterior descending artery \[LAD\], left circumflex artery \[LCX\], right coronary artery \[RCA\])
You may not qualify if:
- Patients with previous coronary artery bypass grafting (CABG)
- Myocardial infarction within 72h of coronary angiography
- Allergy to the contrast agent or adenosine
- Left main coronary artery stenosis ≥ 50%
- Target vessel with in-stent restenosis
- Target vessel with severe tortuosity or angulation
- % occlusion of target vessel
- Target vessel spasm or injury
- Target vessel with severe myocardial bridge
- Target vessel with severe thrombosis
- Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion
- Presence of false lumen at target vessel based on IVUS
- A serum creatinine level \>150 umol/l, or a glomerular filtration rate \< 45 ml/kg/1.73 m\^2
- Heart failure
- Ineligible for diagnostic intervention (IVUS or FFR examination)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
- School of Biomedical Engineering, Shanghai Jiao Tong Universitycollaborator
- Erasmus Medical Centercollaborator
Study Sites (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Fenghua Ding
- Organization
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Study Officials
- PRINCIPAL INVESTIGATOR
Fenghua Ding, MD, PhD
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2023
First Posted
January 23, 2023
Study Start
February 17, 2023
Primary Completion
November 22, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
November 24, 2025
Results First Posted
November 24, 2025
Record last verified: 2025-08